Well Health forms partnership with AliveCor

Executive Summary

• Well Health Technologies Corp. has entered into a strategic partnership with AliveCor Inc. to integrate AI-powered cardiac monitoring with Canadian cardiologist oversight.
• The collaboration allows Canadian users of AliveCor’s Kardia ECG technology to request clinical reviews from Well Health’s network of registered cardiologists, who provide comprehensive evaluations and written guidance within 24 hours.
• The partnership aims to address constrained access to cardiology services in Canada by reducing wait times and creating a new revenue stream for Well Health through clinical service fees.

Key Details

• Partnership Structure: Well Health provides a network of Canadian-registered cardiologists to review ECGs recorded by users of AliveCor’s Kardia devices and app.
• Service Workflow:
  • Patients record an ECG using a Kardia device.
  • AliveCor’s Health Canada-licensed AI algorithms instantly detect common heart arrhythmias in a 30-second recording.
  • Users can request a clinician review via the Kardia app.
  • A Well Health cardiologist evaluates the ECG within 24 hours, confirming or refining the AI result and providing written physician guidance on next steps.
• Financial Impact: Well Health is compensated for each cardiologist review performed, generating clinical services revenue.
• Market Context: The service addresses a 53% increase in elective cardiology wait times over the last year, with patients averaging 15.3 weeks for specialist consultation.
• Future Expansion: The launch is Phase 1 of the partnership. Future phases may include deploying AliveCor’s Kardia 12L (a pocket-sized, AI-powered 12-lead ECG system) within Well’s clinic network for primary, urgent, and outpatient care.
• Company Scale: Well Health operates the largest owned and operated outpatient health care ecosystem in Canada with more than 250 clinics and technology solutions enabling over 43,000 health care providers across Canada and the United States.

Notable Quotes

• Dina Sergi, CEO of Well Health Diagnostic Centres: "This partnership pairs the clinical expertise of Well's cardiologist network with some of the most advanced AI-powered cardiac monitoring technology in the world. By providing clinician review to AliveCor's AI-driven analysis, we are helping patients get answers faster, reducing pressure on the health care system and creating a new, scalable clinical services revenue stream for Well."
• Navneet Malpani, Senior Vice-President of Partner Alliances at AliveCor: "AliveCor is committed to delivering the most clinically validated heart care tools to patients worldwide. By partnering with Well Health, Canada's leader in modern outpatient care, we are providing our Canadian customers with an essential layer of clinical oversight. Patients can receive expert guidance from a certified cardiologist when they need it most, without having to wait for in-person appointments."